A review of systemic lupus erythematosus and current treatment options; Focus on bazedoxefine; Agents in late-stage development for major depressive disorder and generalized anxiety disorder
FDA Issues Complete Response for High-Dose Opioid Rescue Med
July 16th 2024OX124 is a nasal spray provides rapid absorption of naloxone for patients experiencing an opioid overdose. The FDA would like to see additional technical data, as well as data on whether patients can correctly use the device.
Read More